1. Pharmacokinetics, safety, tolerability and immunogenicity of FKB327, a new biosimilar medicine of adalimumab/Humira, in healthy subjects. (9th March 2017) Authors: Puri, Adeep; Niewiarowski, Andrew; Arai, Yasumasa; Nomura, Hideaki; Baird, Mark; Dalrymple, Isobel; Warrington, Steve; Boyce, Malcolm Journal: British journal of clinical pharmacology Issue: Volume 83:Number 7(2017) Page Start: 1405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗